公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2009 | Reimbursement Policies in Asia-Pacific for Chronic Hepatitis B | KAO, JIA-HORNG | HEPATOLOGY | | | |
2016 | Reply | TUNG-HUNG SU ; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology (Baltimore, Md.) | 0 | 0 | |
2024 | Reply | SHANG-CHIN HUANG ; Su, Tung-Hung; Kao, Jia-Horng | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | | | |
2015 | Reply to: Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients | Huang, Yi-Wen; Yang, Sien-Sing; Kao, Jia-Horng | Antiviral Therapy | 0 | 0 | |
2012 | Risk stratification for HBV-related HCC | Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
2013 | Risk stratification for hepatitis B virus related hepatocellular carcinoma | Lin, Chih-Lin; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
2014 | Safety and efficacy outcomes of all-oral daclatasvir-containing regimens in patients with or without cirrhosis in phase 2 and 3 studies | Jensen, Donald M.; Jacobson, Ira M.; Kumada, Hiromitsu; Toyota, Joji; Sulkowski, Mark S.; Manns, Michael P.; Kao, Jia-Horng; Heo, Jeong; Yin, Philip; Mendez, Patricia; Hughes, Eric A.; Noviello, Stephanie | Hepatology | | | |
2014 | Safety and efficacy outcomes of all-oral daclatasvir-containing regimens in patients with or without cirrhosis in phase 2 and 3 studies | Jensen, Donald M.; Jacobson, Ira M.; Kumada, Hiromitsu; Toyota, Joji; Sulkowski, Mark S.; Manns, Michael P.; Kao, Jia-Horng; Heo, Jeong; Yin, Philip; Mendez, Patricia; Hughes, Eric A.; Noviello, Stephanie | Hepatology | | | |
2009 | Serum Hepatitis B Virus DNA Level at One Year after Hepatitis B E Antigen Seroconversion Predicts Subsequent Hepatitis B Reactivation | TSENG, TAI-CHUNG; LIU, CHUN-JEN; WANG, CHIA-CHI; CHEN, PEI-JER; LAI, MING-YANG; CHEN, DING-SHINN; KAO, JIA-HORNG | JOURNAL OF HEPATOLOGY | | | |
2009 | Serum Hepatitis B Virus DNA Level at One Year Post Hepatitis B E Antigen Seroconversion Predicts Subsequent Liver Cirrhosis Development | LIU, CHUN-JEN; CHEN, PEI-JER; LAI, MING- YANG; CHEN, DING-SHINN; KAO, JIA-HORNG | HEPATOLOGY | | | |
2015 | Serum viral load is not the major determinant of hepatocellular carcinoma risk in chronic hepatitis B patients with compensated liver cirrhosis | Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Wan-Ting; Yang, Hung-Chih; Chen, Chi-Ling; Su, Tung-Hung; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
2015 | Serum viral load is not the major determinant of hepatocellular carcinoma risk in chronic hepatitis B patients with compensated liver cirrhosis | Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Wan-Ting; Yang, Hung-Chih; Chen, Chi-Ling; Su, Tung-Hung; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
1993 | Sexual Transmission of Hepatitis C Virus | Kao, Jia-Horng; 高嘉宏 | Lancet | | | |
2014 | Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study | Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen | Hepatology | | | |
2014 | Significant Reduction of Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with Peg-interferon plus Ribavirin Therapy: A Five-year Clinical Cohort Study | Lee, Mei-Hsuan; Yuan, Yong; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Liu, Chen-Hua; Lu, Sheng-Nan; Sheen, I-Shyan; L'Italien, Gilbert J.; Yang, Hwai-I; Chen, Chien-Jen | Hepatology | | | |
2014 | Supersonic shear imaging predicts cirrhosis and advanced fibrosis in chronic hepatitis C patients | Hsu, Shih-Jer; Tan, Yu L.; Chen, Ding-Shinn; Kao, Jia-Horng | Hepatology | | | |
2014 | Supersonic shear imaging predicts cirrhosis and advanced fibrosis in chronic hepatitis C patients | Hsu, Shih-Jer; Tan, Yu L.; Chen, Ding-Shinn; Kao, Jia-Horng | Hepatology | | | |
2009 | Telaprevir for Chronic Hcv Infection | KAO, JIA-HORNG | NEW ENGLAND JOURNAL OF MEDICINE | | | |